Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options.
The recent literature shows that interest in ocular adnexal lymphomas and their biologic and clinical characteristics--along with their possible association with Chlamydia psittaci infection and therapeutic management with rituximab or anti-Chlamydia psittaci antibiotic therapy--is considerable. These new data have modified the previously reported features of this disease and have made an updated review of the literature necessary. The aims of this review are to present the current knowledge on the biology of these lymphomas, their clinical features and prognostic factors, and the panel of all available treatment options.
Decaudin
Didier
D
Service d'Hématologie, Institut Curie, 26 rue d'Ulm, 75.248 Paris cedex 05, France. didier.decaudin@curie.net.
de Cremoux
Patricia
P
Vincent-Salomon
Anne
A
Dendale
Remi
R
Rouic
Livia Lumbroso-Le
LL
D002690:Chlamydia Infections / Q000150:complications; D005134:Eye Neoplasms / Q000235:genetics / Q000382:microbiology / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000235:genetics / Q000382:microbiology / Q000473:pathology* / Q000628:therapy; D009367:Neoplasm Staging; D011379:Prognosis; D016896:Treatment Outcome